Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-11-18
- Last Posted Date
- 2014-08-29
- Lead Sponsor
- Novocol Pharmaceutical of Canada, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT01474382
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸Indiana University School of Dentistry, Indianapolis, Indiana, United States
🇺🇸University of Pennsylvania School of Dental, Philadelphia, Pennsylvania, United States
© Copyright 2024. All Rights Reserved by MedPath